These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8082010

  • 1. Endothelin and renal disease progression.
    Remuzzi G, Benigni A.
    Exp Nephrol; 1994; 2(2):133. PubMed ID: 8082010
    [No Abstract] [Full Text] [Related]

  • 2. The glomerular mesangium: role in initiation and progression of renal injury.
    Shultz PJ, Raij L.
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):8-14. PubMed ID: 2024680
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of mesangial cell proliferation by antisense oligodeoxynucleotide targeting preproendothelin-1 mRNA in vitro.
    Li M, Chen Y, Zhang Z, Gao J.
    Chin Med J (Engl); 1999 Sep; 112(9):790-3. PubMed ID: 11717946
    [Abstract] [Full Text] [Related]

  • 4. Time course and localization of endothelin-1 gene expression in a model of renal disease progression.
    Bruzzi I, Corna D, Zoja C, Orisio S, Schiffrin EL, Cavallotti D, Remuzzi G, Benigni A.
    Am J Pathol; 1997 Nov; 151(5):1241-7. PubMed ID: 9358749
    [Abstract] [Full Text] [Related]

  • 5. Prepro-endothelin-1 mRNA and its mature peptide in human appendix.
    Massai L, Carbotti P, Cambiaggi C, Mencarelli M, Migliaccio P, Muscettola M, Grasso G.
    Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G340-8. PubMed ID: 12529269
    [Abstract] [Full Text] [Related]

  • 6. Potential contribution of endothelin to renal abnormalities in glycerol-induced acute renal failure in rats.
    Shimizu T, Kuroda T, Ikeda M, Hata S, Fujimoto M.
    J Pharmacol Exp Ther; 1998 Aug; 286(2):977-83. PubMed ID: 9694958
    [Abstract] [Full Text] [Related]

  • 7. [Endothelins: possibly a new pharmacological approach in cardiovascular diseases, kidney diseases and oncological disorders].
    Kroodsma JM, Rabelink AJ.
    Ned Tijdschr Geneeskd; 1997 Sep 20; 141(38):1806-10. PubMed ID: 9545734
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment with CsA decreases INF-gamma mRNA and increases pre-pro-ET-1 mRNA in rat kidneys.
    Murer L, Giacomini A, Gambaro G, Del Prete D, Dall'Amico R, Pagetta E, Zacchello G, Anglani F.
    Transplant Proc; 1998 Jun 20; 30(4):950-1. PubMed ID: 9636383
    [No Abstract] [Full Text] [Related]

  • 9. Salvianolate inhibits proliferation and endothelin release in cultured rat mesangial cells.
    Xu M, Wang YP, Luo WB, Xuan LJ.
    Acta Pharmacol Sin; 2001 Jul 20; 22(7):629-33. PubMed ID: 11749828
    [Abstract] [Full Text] [Related]

  • 10. Human tubular-derived endothelin in the paracrine regulation of renal interstitial fibroblast function.
    Ong AC, Jowett TP, Firth JD, Burton S, Kitamura M, Fine LG.
    Exp Nephrol; 1994 Jul 20; 2(2):134. PubMed ID: 8082011
    [No Abstract] [Full Text] [Related]

  • 11. Endothelin: a mediator of renal disease progression.
    Bruzzi I, Remuzzi G, Benigni A.
    J Nephrol; 1997 Jul 20; 10(4):179-83. PubMed ID: 9377723
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanism of progression of renal disease: growth factors and related mechanisms.
    Benigni A, Remuzzi G.
    J Hypertens Suppl; 1998 Sep 20; 16(4):S9-12. PubMed ID: 9817186
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Inhibition of mesangial cell proliferation and mesangial matrix expansion by antisense oligodeoxynucleotide targeting preproendothelin-1 mRNA in vivo].
    Li M, Chen Y, Zhang Z.
    Zhonghua Yi Xue Za Zhi; 1999 Feb 20; 79(2):133-5. PubMed ID: 11601021
    [Abstract] [Full Text] [Related]

  • 16. [The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure].
    Orisio S, Zoja C, Remuzzi G.
    Ann Ital Med Int; 1993 Feb 20; 8(4):213-7. PubMed ID: 8161475
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells.
    Morin C, Asselin C, Boudreau F, Provencher PH.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):583-7. PubMed ID: 9514952
    [Abstract] [Full Text] [Related]

  • 18. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C.
    Transplantation; 2007 Dec 15; 84(11):1492-9. PubMed ID: 18091526
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.